In yesterday’s Wall Street session, Gritstone Bio Inc (NASDAQ:GRTS) shares traded at $0.62, down -12.42% from the previous session.
GRTS stock price is now -22.09% away from the 50-day moving average and -63.30% away from the 200-day moving average. The market capitalization of the company currently stands at $67.09M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $4, JMP Securities recently initiated with Mkt Outperform rating for Gritstone Bio Inc (NASDAQ: GRTS). , while ‘B. Riley Securities’ rates the stock as ‘Buy’
In other news, Allen Andrew R, PRESIDENT AND CEO sold 24,263 shares of the company’s stock on May 16 ’24. The stock was sold for $18,156 at an average price of $0.75. Upon completion of the transaction, the PRESIDENT AND CEO now directly owns 985,360 shares in the company, valued at $0.61 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 16 ’24, EVP, CHIEF OPERATING OFFICER Jones Erin sold 13,749 shares of the business’s stock. A total of $10,288 was realized by selling the stock at an average price of $0.75. This leaves the insider owning 359,293 shares of the company worth $0.22 million. A total of 8.23% of the company’s stock is owned by insiders.
During the past 12 months, Gritstone Bio Inc has had a low of $0.67 and a high of $3.33. As of last week, the company has a debt-to-equity ratio of 7.40, a current ratio of 1.99, and a quick ratio of 1.99. The fifty day moving average price for GRTS is $0.7904 and a two-hundred day moving average price translates $1.67775 for the stock.
The latest earnings results from Gritstone Bio Inc (NASDAQ: GRTS) was released for 2024-03-31. The net profit margin was -17269.73% and return on equity was -187.15% for GRTS. The company reported revenue of $1.74 million for the quarter, compared to $2.44 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -28.69 percent.
